martes, 4 de noviembre de 2014

National Guideline Clearinghouse | The official positions of the International Society for Clinical Densitometry: indications of use and reporting of DXA for body composition.

FULL-TEXT ►

National Guideline Clearinghouse | The official positions of the International Society for Clinical Densitometry: indications of use and reporting of DXA for body composition.



International Society for Clinical Densitometry

National Guideline Clearinghouse (NGC)

Guideline Title
The official positions of the International Society for Clinical Densitometry: indications of use and reporting of DXA for body composition.
Bibliographic Source(s)
Kendler DL, Borges JL, Fielding RA, Itabashi A, Krueger D, Mulligan K, Camargos BM, Sabowitz B, Wu CH, Yu EW, Shepherd J. The official positions of the International Society for Clinical Densitometry: indications of use and reporting of DXA for body composition. J Clin Densitom. 2013 Oct-Dec;16(4):496-507. [137 references] PubMed External Web Site Policy
Guideline Status
This is the current release of the guideline.

 2013 Oct-Dec;16(4):496-507. doi: 10.1016/j.jocd.2013.08.020. Epub 2013 Oct 16.

The Official Positions of the International Society for Clinical Densitometry: Indications of Use and Reporting of DXA for Body Composition.

Abstract

The technique of body composition by dual-energy X-ray absorptiometry (DXA) has been used for several years in the research environment. Its ability to accurately and precisely measure lean, fat, and mineral composition in various body compartments has been well validated. Furthermore, the technique is widely available to clinical patients on existing DXA instruments throughout the world through the use of specific software packages and scanning algorithms. There have been few clear statements regarding the clinical indications for body composition measurement in patients outside the research setting. This is in part because of the lack of specific documented interventions that would be affected by body composition test results, beyond usual clinical advice. We have examined a few of the most common, specific scenarios (HIV therapy, sarcopenia, bariatric surgery, obesity) and proposed indications for body composition assessment. We have also discussed contraindications to body composition testing.
Copyright © 2013 The International Society for Clinical Densitometry. Published by Elsevier Inc. All rights reserved.

KEYWORDS:

Body composition; DXA; obesity; sarcopenia

PMID:
 
24090645
 
[PubMed - indexed for MEDLINE]

No hay comentarios:

Publicar un comentario